報價延遲最少15分鐘:2025/09/14 16:50 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
9.32 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.24/--
|
|
企業價值
441.27M
|
| 資產負債 |
|
每股賬面淨值
0.84
|
| 現金流量 |
|
現金流量率
0.01
|
| 損益表 |
|
收益
186.36M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/09/14 16:50 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry, and other vaccines. |
